Nu Med Plus Stock Price on October 17, 2023
| NUMD Stock | USD 0.01 0 10.00% |
If you're considering investing in NUMD OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Nu Med stands at 0.01, as last reported on the 22nd of December, with the highest price reaching 0.01 and the lowest price hitting 0.01 during the day. Nu Med Plus retains Efficiency (Sharpe Ratio) of -0.12, which conveys that the firm had a -0.12% return per unit of price deviation over the last 3 months. Nu Med exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Nu Med's Information Ratio of (0.12), market risk adjusted performance of (0.49), and Mean Deviation of 7.25 to check out the risk estimate we provide.
NUMD OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
NUMD |
Sharpe Ratio = -0.1167
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NUMD |
Estimated Market Risk
| 11.92 actual daily | 96 96% of assets are less volatile |
Expected Return
| -1.39 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Nu Med is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nu Med by adding Nu Med to a well-diversified portfolio.
Nu Med Valuation on October 17, 2023
It is possible to determine the worth of Nu Med on a given historical date. On October 17, 2023 NUMD was worth 0.0145 at the beginning of the trading date compared to the closed value of 0.0188. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Nu Med otc stock. Still, in general, we apply an absolute valuation method to find Nu Med's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nu Med where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Nu Med's related companies.
| Open | High | Low | Close | Volume | |
| 0.02 | 0.02 | 0.02 | 0.02 | 1.00 | |
10/17/2023 | 0.01 | 0.02 | 0.01 | 0.02 | 5,200 |
| 0.02 | 0.02 | 0.02 | 0.02 | 1.00 |
| Backtest Nu Med | | | Nu Med History | | | Nu Med Valuation | Previous | Next |
Nu Med Trading Date Momentum on October 17, 2023
| On October 18 2023 Nu Med Plus was traded for 0.02 at the closing time. The top price for the day was 0.02 and the lowest listed price was 0.02 . There was no trading activity during the period 1.0. Lack of trading volume on October 18, 2023 did not cause price change. The trading delta at closing time against the current closing price is 17.02% . |
Nu Med Plus Fundamentals Correlations and Trends
By evaluating Nu Med's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Nu Med's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. NUMD financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Nu Med OTC Stock history
Nu Med investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NUMD is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Nu Med Plus will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Nu Med stock prices may prove useful in developing a viable investing in Nu Med
Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. Nu-Med Plus, Inc. was incorporated in 2011 and is headquartered in Salt Lake City, Utah. Nu Med operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 2 people.
Nu Med OTC Stock Technical Analysis
Nu Med technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Price Boundaries
Nu Med Period Price Range
Low | December 22, 2024
| High |
0.00 | 0.00 |
Nu Med Plus cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Nu Med December 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Nu Med otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nu Med shares will generate the highest return on investment. By undertsting and applying Nu Med otc stock market strength indicators, traders can identify Nu Med Plus entry and exit signals to maximize returns
Nu Med Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Nu Med's price direction in advance. Along with the technical and fundamental analysis of NUMD OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NUMD to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (1.44) | |||
| Total Risk Alpha | (1.71) | |||
| Treynor Ratio | (0.50) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for NUMD OTC Stock analysis
When running Nu Med's price analysis, check to measure Nu Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Med is operating at the current time. Most of Nu Med's value examination focuses on studying past and present price action to predict the probability of Nu Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Med's price. Additionally, you may evaluate how the addition of Nu Med to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |